I now have all the core textbook content needed. Let me compile the comprehensive MD Anesthesia exam answer.
Anesthetic Management of Patients with Ischemic Heart Disease
Hemodynamic Goals of Induction and Maintenance of General Anesthesia
Core Pathophysiological Principle
The single overriding objective in managing patients with ischemic heart disease (IHD) is maintaining a favorable myocardial oxygen supply-demand relationship. Every hemodynamic goal derives from this principle.
Myocardial ischemia occurs when oxygen demand exceeds supply. Unlike other tissues that can compensate for reduced flow by increasing oxygen extraction, the myocardium already extracts 65% of arterial oxygen at rest (coronary sinus O₂ saturation ~30%). Therefore, any increase in demand must be met by increased coronary blood flow - which is impaired in IHD.
Determinants of Myocardial O₂ Supply and Demand
| Supply | Demand |
|---|
| Heart rate (diastolic filling time) | Heart rate |
| Coronary perfusion pressure (Aortic DBP - LVEDP) | Wall tension (Preload - ventricular radius; Afterload) |
| Arterial O₂ content (PaO₂, Hb) | Contractility (inotropy) |
| Coronary vessel diameter | Basal metabolic requirements |
Key point: Heart rate and LVEDP appear on both sides - they are the most critical determinants to control perioperatively.
Left coronary perfusion pressure = Aortic Diastolic Pressure - LVEDP
- The left ventricle is perfused almost entirely during diastole
- Tachycardia disproportionately reduces diastolic time, simultaneously increasing demand and reducing supply - the most dangerous combination in IHD
- The right ventricle is perfused during both systole and diastole
HEMODYNAMIC GOALS
1. Heart Rate - THE MOST CRITICAL PARAMETER
Target: 50-70 bpm (normal sinus rhythm, avoid tachycardia)
- Tachycardia is the most common precipitant of perioperative ischemia; it increases demand and reduces supply simultaneously
- Disproportionate shortening of diastolic time at higher heart rates (diastolic time falls non-linearly with HR) directly limits coronary perfusion
- Bradycardia <45 bpm should also be avoided as it reduces cardiac output
- The most common hemodynamic abnormalities seen during ischemic episodes are hypertension and tachycardia - they are almost always the cause (not the result) of ischemia
How to maintain:
- Adequate depth of anesthesia before laryngoscopy
- Opioid preloading (fentanyl 2-5 mcg/kg before intubation) to blunt laryngoscopy response
- Beta-blockers (esmolol 0.5-1 mg/kg IV) to treat intraoperative tachycardia
- Volatile agents (all have rate-lowering tendency at adequate MAC)
- Avoid anticholinergic tachycardia; if needed for bradycardia, use glycopyrrolate (less tachycardia than atropine)
2. Blood Pressure - Maintain in a Narrow Range
Target: Within ±20% of baseline; avoid both hypertension and hypotension
A. Hypertension
- Increases afterload → increases wall tension → increases O₂ demand
- Hypertension during laryngoscopy/intubation is one of the most dangerous moments
- Down-sloping/horizontal ST depression almost always accompanies severe hypertensive responses in IHD patients
- Management: adequate depth (volatile agent titration), iv fentanyl, β-blockers, nitroglycerin, nicardipine
B. Hypotension
- Reduces coronary perfusion pressure (Aortic DBP - LVEDP)
- Hypotension is a late and ominous manifestation of progressive ventricular dysfunction
- Higher diastolic pressures are preferable in patients with high-grade coronary occlusions
- The endocardium is most vulnerable to ischemia during hypotension (highest intramural pressures during systole)
- Management: vasopressors (phenylephrine preferred - pure α-agonist, does not increase HR; norepinephrine if cardiac output low); treat cause (hypovolemia, vasodilation from anesthetics, myocardial depression)
3. Preload (LVEDP / Filling Pressures)
Target: Avoid extremes - maintain "euvolemia"
- Excessive preload (fluid overload): Increases LVEDP → reduces coronary perfusion pressure (supply falls) AND increases ventricular wall tension (demand rises) - a double jeopardy
- Elevated LVEDP specifically reduces subendocardial perfusion
- Hypovolemia: Reduces preload → reduces cardiac output → hypotension → reduces coronary perfusion
- Optimal filling: guided by clinical assessment, arterial waveform variation, or TEE (LV chamber size)
- PAC-measured PCWP rises abruptly with ischemia (though PAC rarely used now)
4. Contractility
Target: Avoid excessive myocardial depression or unnecessary inotropic stimulation
- Increased contractility = increased O₂ demand
- Excessive anesthetic-induced depression → low CO → hypotension → reduced perfusion
- Most volatile agents are mildly negatively inotropic - this is acceptable and even beneficial at moderate doses (reduce demand, reduce preload/afterload)
- Volatile agents also exert anesthetic preconditioning - activate ATP-sensitive K⁺ channels, reduce reperfusion injury, help "stunned" myocardium recover
- Avoid catecholamine surges (laryngoscopy, surgical stimulation) - they massively increase contractility and HR simultaneously
5. Systemic Vascular Resistance (Afterload)
Target: Avoid marked elevation or reduction
- High SVR → increased wall tension → increased O₂ demand
- Low SVR → hypotension → reduced coronary perfusion pressure
- The goal is stable SVR within normal limits
6. Arterial Oxygen Content (CaO₂)
Target: SpO₂ >99%, Hb ≥7-8 g/dL
- Maintain adequate oxygenation and ventilation throughout
- Anemia → compensatory tachycardia → worsens supply-demand balance
- Most clinicians are reluctant to allow Hb <7 g/dL in CAD patients; transfusion decision is individualized
- Hypoventilation with resulting hypoxia and hypercarbia (both cause sympathetic stimulation and tachycardia) must be avoided
INDUCTION - SPECIFIC GOALS AND STRATEGIES
The Critical Period: Induction and Laryngoscopy
Induction and intubation represent the highest-risk hemodynamic period because:
- Anesthetic agents cause vasodilation/myocardial depression → risk of hypotension
- Laryngoscopy causes intense sympathetic stimulus → tachycardia and hypertension
The hemodynamic "ideal" for induction:
| Parameter | Goal |
|---|
| HR | 60-70 bpm, no tachycardia >90 bpm |
| SBP | ±20% of baseline, avoid >160 mmHg or sudden fall |
| DBP | Maintain (ensures coronary perfusion) |
| MAP | ≥60-70 mmHg |
| No rhythm change | Sinus rhythm maintained |
Induction Agents
- Propofol: Most commonly used; causes vasodilation and mild myocardial depression - titrate slowly to avoid sudden hypotension; use with opioid preloading
- Etomidate: Hemodynamically most stable (minimal CVS effects) - preferred when LV function is compromised; causes minimal change in HR, BP, and SVR; however does not blunt laryngoscopy response
- Ketamine: Generally avoided in IHD - sympathomimetic properties increase HR, BP, and O₂ demand; occasionally used when hemodynamics are very compromised
- Thiopental: Historically used, causes vasodilation and mild myocardial depression
Blunting Laryngoscopy Response
This is a key intraoperative goal. Options include:
- Opioid preloading - fentanyl 2-5 mcg/kg, remifentanil infusion
- Lignocaine IV - 1.5 mg/kg given 90 seconds before intubation
- Beta-blockers - esmolol 1-2 mg/kg bolus before laryngoscopy
- Topical laryngeal analgesia - 4% lignocaine spray
- Adequate depth - deep enough volatile anesthetic or propofol before laryngoscopy
- Keep laryngoscopy brief - <15 seconds; use video laryngoscope
MAINTENANCE - SPECIFIC GOALS
Choice of Anesthetic Agents
Volatile agents (isoflurane, sevoflurane, desflurane) are preferred:
- All are coronary vasodilators
- Reduce myocardial O₂ requirements
- Provide anesthetic preconditioning (cardioprotection via KATP channels)
- Reduce preload and afterload at moderate doses
- Caveat: Desflurane causes sympathetic stimulation during rapid increases in concentration → avoid rapid up-titration in IHD
TIVA (propofol-based) is an acceptable alternative:
- ACC/AHA Class IIa recommendation: either volatile or TIVA is reasonable (LOE: A)
- Propofol reduces preload and afterload but lacks preconditioning benefit
Opioids:
- High-dose opioid techniques provide excellent hemodynamic stability
- Fentanyl, sufentanil, remifentanil - blunt sympathetic responses, minimal direct cardiac depression
- Remifentanil infusion is particularly useful for moment-to-moment titration
Neuromuscular Blockade:
- Vecuronium or rocuronium preferred (minimal cardiovascular effects)
- Avoid pancuronium (vagolytic - causes tachycardia)
- Avoid succinylcholine as primary agent if not needed urgently (fasciculations → transient increases in IOP and oxygen demand)
Maintaining Hemodynamic Stability During Surgery
Treat tachycardia promptly:
- Increase depth of anesthesia
- Esmolol (short-acting β-blocker) or metoprolol
- Address pain/light anesthesia
- Ensure adequate analgesia
Treat hypertension:
- Deepen anesthesia, increase volatile agent
- Nicardipine, labetalol, or GTN infusion
- Ensure adequate opioid analgesia
Treat hypotension:
- Reduce anesthetic depth
- IV fluid bolus if hypovolemic
- Phenylephrine (if BP low, HR normal/high)
- Ephedrine (if BP low, HR low)
- Check ECG for new ischemia immediately
Temperature
- Maintain normothermia - hypothermia → shivering post-op → massive increase in O₂ demand; ACC/AHA Class IIb recommendation
MONITORING REQUIREMENTS
| Monitor | Rationale |
|---|
| ECG - Leads II and V5 simultaneously | II: inferior ischemia + arrhythmias; V5: anterior wall (most sensitive single lead) |
| Invasive arterial BP | Continuous beat-to-beat BP, access for ABG |
| SpO₂ and capnography | Continuous oxygenation, ventilation |
| Temperature | Normothermia |
| Urine output | Renal perfusion as surrogate for CO |
| TEE (if available) | Earlier and more sensitive than ECG for ischemia detection (new RWMA); also assesses volume status |
| Central venous access | Major procedures, vasoactive drug delivery |
ECG lead sensitivity for ischemia detection: V5 > V4 > II > V2 > V3
Ischemia on ECG: T-wave inversion (earliest) → ST depression (horizontal or down-sloping >1mm) → ST elevation (severe/transmural ischemia or vasospasm)
TEE advantage: New regional wall motion abnormalities (RWMA) develop before ECG changes when coronary flow is gradually reduced - more sensitive early indicator.
SUMMARY TABLE: Hemodynamic Goals in IHD
| Parameter | Target | Rationale |
|---|
| Heart Rate | 50-70 bpm | Tachycardia = #1 cause of ischemia; ↑HR → ↑demand + ↓supply |
| Systolic BP | ±20% of baseline | Hypertension ↑wall tension (demand); hypotension ↓CPP (supply) |
| Diastolic BP | Maintain or slightly elevated | CPP = Aortic DBP - LVEDP; DBP critical for LV perfusion |
| MAP | ≥65-70 mmHg | Minimum for coronary autoregulation |
| LVEDP (preload) | Euvolemia | High LVEDP: ↓CPP + ↑wall tension; low: ↓CO + hypotension |
| Contractility | Normal | Excessive inotropic state ↑demand |
| SVR (afterload) | Normal | ↑SVR → ↑wall tension; ↓SVR → hypotension |
| SpO₂ | >99% | CaO₂ is a supply determinant |
| Hemoglobin | ≥7-8 g/dL | Anemia → compensatory tachycardia |
| Temperature | Normothermia | Hypothermia → shivering → massive ↑demand |
KEY EXAM POINTS TO REMEMBER
- Tachycardia is the enemy - it simultaneously increases demand and reduces supply by shortening diastole
- Coronary perfusion pressure = Aortic DBP - LVEDP - both sides of this equation matter
- The myocardium cannot increase oxygen extraction (already near-maximal at rest) - supply must match demand
- Volatile agents are cardioprotective via preconditioning (KATP channel activation) - this is a pharmacological advantage over TIVA
- Hypotension is a late sign of ventricular dysfunction - by the time BP falls due to ischemia, significant myocardium is already compromised; the goal is to prevent this from happening
- Induction and laryngoscopy are the highest-risk periods - use opioid preloading, adequate depth, and short laryngoscopy time
- Etomidate is the hemodynamically most stable induction agent - preferred in compromised LV function
- Pancuronium is contraindicated - vagolytic tachycardia
- TEE > ECG for early ischemia detection (RWMA precede ST changes)
- ACC/AHA: Either volatile or TIVA is acceptable (Class IIa, LOE A); prophylactic intraoperative nitroglycerin is not recommended (Class III: No Benefit)
Sources: Morgan and Mikhail's Clinical Anesthesiology, 7e - Chapters 20 (Cardiovascular Physiology), 21 (Anesthesia for Patients with Cardiovascular Disease); ACC/AHA 2014 Guidelines on Perioperative Cardiovascular Evaluation and Management